SK

Sanjay Kumar Sinha

Active Director Managing Director DIN 02600061
DIN 02600061 First appointment May 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Past companies 5 historical roles
Total affiliations 7 Since May 2009
Shareholding value •••• Premium profile

About Sanjay Kumar Sinha

Data last updated:

Sanjay Kumar Sinha is a Managing Director at Hauz Pharma Private Limited (since 2009) and Director at Sanovia Biotech Private Limited (since 2016). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹32.14 Cr; the largest is Hauz Pharma Private Limited at ₹30.46 Cr (FY 2024). Earlier, Sanjay Kumar Sinha was a Director at Ultra Biolabs Private Limited (2011–2015) and Director at Zentis Drugs Private Limited (2010–2011) and 3 more.

DIN 02600061
Primary Designation Managing Director
Industry Pharma
First Appointment 29 May 2009
Oldest Company Age 17 yrs
Largest company Hauz Pharma Private Limited · ₹30.46 Cr (FY 2024)
Combined revenue ₹32.14 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hauz Pharma Private Limited U24232CH2009PTC031626
Managing Director29 May 20092009₹30.46 Cr (FY 2024)Active
Sanovia Biotech Private Limited U24304HR2016PTC066063
Director10 Oct 20162016₹1.68 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ultra Biolabs Private Limited U24100HR2011PTC099249
Director20 Apr 20112011₹10.26 Cr (FY 2024)Active
Zentis Drugs Private Limited U24100HR2010PTC040302
Director29 Mar 20102010₹1.20 Cr (FY 2025)Active
Alisier Drugs Private Limited U24232HR2011PTC044698
Director04 Mar 20152011₹3.06 Cr (FY 2024)Active
Eviza Biotech Private Limited U24232CH2014PTC034940
Director28 Jan 20142014₹2.51 Cr (FY 2025)Active
Ultra Health Care Private Limited U85110CH2012PTC033534
Director01 Feb 20122012Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sanjay Kumar Sinha

Directorship timeline

Open interactive timeline →
Hauz Pharma Private Limited
Sanovia Biotech Private Limited
Ultra Health Care Private Limited
Ultra Biolabs Private Limited
Premium access

Shareholding and investment profile for Sanjay Kumar Sinha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Kumar Sinha

Sanjay Kumar Sinha currently holds 2 directorships: Hauz Pharma Private Limited (Managing Director, since 29 May 2009, revenue ₹30.46 Cr (FY 2024)); Sanovia Biotech Private Limited (Director, since 10 Oct 2016, revenue ₹1.68 Cr (FY 2025)).

Sanjay Kumar Sinha was first appointed on 29 May 2009 as Managing Director at Hauz Pharma Private Limited. The most recent appointment on record is 10 Oct 2016 at Sanovia Biotech Private Limited.

The 2 current companies of Sanjay Kumar Sinha that report revenue have a combined latest revenue of ₹32.14 Cr: Hauz Pharma Private Limited ₹30.46 Cr (FY 2024); Sanovia Biotech Private Limited ₹1.68 Cr (FY 2025).

Sanjay Kumar Sinha held 5 earlier board appointments: Ultra Biolabs Private Limited (Director, 20 Apr 2011 to 01 Dec 2015); Zentis Drugs Private Limited (Director, 29 Mar 2010 to 04 Jun 2011); Alisier Drugs Private Limited (Director, 04 Mar 2015 to 02 Apr 2016); Eviza Biotech Private Limited (Director, 28 Jan 2014 to 30 Jul 2014); Ultra Health Care Private Limited (Director, from 01 Feb 2012).

The current boards of Sanjay Kumar Sinha's companies include Vikas Sharma (Hauz Pharma Private Limited), Manoj Nigam (Sanovia Biotech Private Limited), Vandna Thakur (Sanovia Biotech Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available